PMC:7283670 / 86389-87044 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T473","span":{"begin":49,"end":52},"obj":"Disease"},{"id":"T474","span":{"begin":147,"end":150},"obj":"Disease"},{"id":"T475","span":{"begin":244,"end":247},"obj":"Disease"}],"attributes":[{"id":"A473","pred":"mondo_id","subj":"T473","obj":"http://purl.obolibrary.org/obo/MONDO_0011194"},{"id":"A474","pred":"mondo_id","subj":"T474","obj":"http://purl.obolibrary.org/obo/MONDO_0011194"},{"id":"A475","pred":"mondo_id","subj":"T475","obj":"http://purl.obolibrary.org/obo/MONDO_0011194"}],"text":"dose group\nSubjects received one dose of 5E10 vp Ad5‐nCoV at 18–60 years old\nExperimental: middle‐dose group\nSubjects received one dose of 1E11 vp Ad5‐nCoV at 18–60 years old\nExperimental: high‐dose group subjects received one dose of 1.5E11vp Ad5‐nCoV at 18–60 years old I Primary (0–7 days postvaccination):\nSafety indexes of adverse reactions\nSecondary (0–28 days postvaccination, within 6 mouths postvaccination):\nSafety indexes of adverse events, Safety indexes of SAE, Safety indexes of lab measures, Immunogencity indexes of GMT (ELISA), Immunogencity indexes of GMT (pseudoviral neutralization test method) (Day 14, 28, Month 6 postvaccination),"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T730","span":{"begin":61,"end":63},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T731","span":{"begin":139,"end":143},"obj":"http://purl.obolibrary.org/obo/CLO_0053809"},{"id":"T732","span":{"begin":159,"end":161},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T733","span":{"begin":256,"end":258},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T734","span":{"begin":395,"end":401},"obj":"http://www.ebi.ac.uk/efo/EFO_0000825"},{"id":"T735","span":{"begin":604,"end":608},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"dose group\nSubjects received one dose of 5E10 vp Ad5‐nCoV at 18–60 years old\nExperimental: middle‐dose group\nSubjects received one dose of 1E11 vp Ad5‐nCoV at 18–60 years old\nExperimental: high‐dose group subjects received one dose of 1.5E11vp Ad5‐nCoV at 18–60 years old I Primary (0–7 days postvaccination):\nSafety indexes of adverse reactions\nSecondary (0–28 days postvaccination, within 6 mouths postvaccination):\nSafety indexes of adverse events, Safety indexes of SAE, Safety indexes of lab measures, Immunogencity indexes of GMT (ELISA), Immunogencity indexes of GMT (pseudoviral neutralization test method) (Day 14, 28, Month 6 postvaccination),"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T343","span":{"begin":5,"end":10},"obj":"Chemical"},{"id":"T344","span":{"begin":103,"end":108},"obj":"Chemical"},{"id":"T345","span":{"begin":199,"end":204},"obj":"Chemical"}],"attributes":[{"id":"A343","pred":"chebi_id","subj":"T343","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A344","pred":"chebi_id","subj":"T344","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A345","pred":"chebi_id","subj":"T345","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"dose group\nSubjects received one dose of 5E10 vp Ad5‐nCoV at 18–60 years old\nExperimental: middle‐dose group\nSubjects received one dose of 1E11 vp Ad5‐nCoV at 18–60 years old\nExperimental: high‐dose group subjects received one dose of 1.5E11vp Ad5‐nCoV at 18–60 years old I Primary (0–7 days postvaccination):\nSafety indexes of adverse reactions\nSecondary (0–28 days postvaccination, within 6 mouths postvaccination):\nSafety indexes of adverse events, Safety indexes of SAE, Safety indexes of lab measures, Immunogencity indexes of GMT (ELISA), Immunogencity indexes of GMT (pseudoviral neutralization test method) (Day 14, 28, Month 6 postvaccination),"}

{"project":"LitCovid-sentences","denotations":[{"id":"T751","span":{"begin":11,"end":76},"obj":"Sentence"},{"id":"T752","span":{"begin":77,"end":108},"obj":"Sentence"},{"id":"T753","span":{"begin":109,"end":174},"obj":"Sentence"},{"id":"T754","span":{"begin":175,"end":311},"obj":"Sentence"},{"id":"T755","span":{"begin":312,"end":347},"obj":"Sentence"},{"id":"T756","span":{"begin":348,"end":419},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"dose group\nSubjects received one dose of 5E10 vp Ad5‐nCoV at 18–60 years old\nExperimental: middle‐dose group\nSubjects received one dose of 1E11 vp Ad5‐nCoV at 18–60 years old\nExperimental: high‐dose group subjects received one dose of 1.5E11vp Ad5‐nCoV at 18–60 years old I Primary (0–7 days postvaccination):\nSafety indexes of adverse reactions\nSecondary (0–28 days postvaccination, within 6 mouths postvaccination):\nSafety indexes of adverse events, Safety indexes of SAE, Safety indexes of lab measures, Immunogencity indexes of GMT (ELISA), Immunogencity indexes of GMT (pseudoviral neutralization test method) (Day 14, 28, Month 6 postvaccination),"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1959","span":{"begin":53,"end":57},"obj":"Species"},{"id":"1960","span":{"begin":151,"end":155},"obj":"Species"},{"id":"1961","span":{"begin":248,"end":252},"obj":"Species"}],"attributes":[{"id":"A1959","pred":"tao:has_database_id","subj":"1959","obj":"Tax:2697049"},{"id":"A1960","pred":"tao:has_database_id","subj":"1960","obj":"Tax:2697049"},{"id":"A1961","pred":"tao:has_database_id","subj":"1961","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"dose group\nSubjects received one dose of 5E10 vp Ad5‐nCoV at 18–60 years old\nExperimental: middle‐dose group\nSubjects received one dose of 1E11 vp Ad5‐nCoV at 18–60 years old\nExperimental: high‐dose group subjects received one dose of 1.5E11vp Ad5‐nCoV at 18–60 years old I Primary (0–7 days postvaccination):\nSafety indexes of adverse reactions\nSecondary (0–28 days postvaccination, within 6 mouths postvaccination):\nSafety indexes of adverse events, Safety indexes of SAE, Safety indexes of lab measures, Immunogencity indexes of GMT (ELISA), Immunogencity indexes of GMT (pseudoviral neutralization test method) (Day 14, 28, Month 6 postvaccination),"}